(Q40635380)
Statements
Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2 (English)
Massimiliano Manganini
Valeria Facchinetti
Rosanna Gramigna
Raewyn Broady
Gianmaria Borleri
Alessandro Rambaldi
1 September 2003